Trade name: Vivotif®, TYPHIM VI®
Generic names: Typhoid Vaccine Live Oral Ty21a, TYPHOID VI POLYSACCHARIDE VACCINE
Indication and Usage: Vivotif (Typhoid Vaccine Live Oral Ty21a) is indicated for immunization of adults and children greater than 6 years of age against disease caused by Salmonella typhi. Typhim Vi vaccine is indicated for active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older.
Manufacturer-listed adverse reactions | Vivotif can cause: Abdominal pain, Nausea, Headache, Fever, Diarrhea, Vomiting, Skin rash, Urticaria (hives), Anaphylactic reaction.
Typhim Vi can cause: Syncope (fainting) with or without convulsions, Nausea, Vomiting, Diarrhea, Abdominal pain, Injection site pain, Lymphadenopathy, Fever, Asthenia, Malaise, Flu-like episode, Anaphylaxis, Pruritus (itchy skin), Rash, Urticaria (hives), Angioedema (swelling), Difficulty breathing, Hypotension, Serum sickness, Myalgia (muscle pain), Arthralgia (joint pain), Cervical pain, Headache, Loss of consciousness, Tremor, Asthma, Neutropenia, Bilateral retinitis, Polyneuritis (nerve damage), Glomerulonephritis (kidney disease).
Need more info? Click the link below for a helpful infographic you can view + save on your device.
